Mid-September marks the start of CLMD’s autumn US/Canadian campaign which features a string of high-profile live appearances.
The NYC-based duo got a breakthrough on the EDM-scene with their chart-topping track The Stockholm Syndrome. After having performed admirably well on European dance charts, the track was re-launched for a US release through Ultra Records in late July.
Over the past year, CLMD has played a number of high-profile gigs. US booking agency Windish have now set up a US tour for the duo to coincide with the North American release of The Stockholm Syndrome.
On August 19 CLMD made their debut appearance on Axwell’s legendary Axtone label with their own take on the classic vocal from Scottish quartet Discopolis in Falling (Committed to Sparkle Motion). Debuted by Axtone’s very own NO_ID on the main stage at this year’s Tomorrowland main stage, subsequent support has come from Above & Beyond, Dirty South, Nicky Romero, Radio 1’s Danny Howard & many more.
CLMD returned to the US earlier this spring with The Stockholm Syndrome on their UpNorth Recordings label in conjunction with Columbia/Sony. This is the follow up to their acclaimed recent singles Falling Like Angels and Black Eyes & Blue (already sold to platina). Given the rapid success of The Stockholm Syndrome, the single was re-released by Ultra Records in July for North America. The song also received heavy support during WMC/Miami Music Week 2013 and has been picked up as the essential new tune for the spring/summer by the biggest stars on the scene.
With the success of The Stockholm Syndrome and the early support of their Discopolis remix on Axtone, CLMD has solidified their position as true rising stars on the EMD scene.
New CLMD releases, remixes and tours are planned for this autumn and winter.
Their single Black Eyes & Blue is notable for being the opening track for the Ultra Music Festival 2012 After Movie. In addition, their releases have achieved major plays from Pete Tong/Radio 1, Tiësto and many of the world’s most famous radio stations.